Amprius Technologies Validates Growth Trajectory With Q2 Earnings—What Comes Next?

Key Points

• Amprius Technologies reported strong Q2 results with 125% year-over-year revenue growth and raised guidance, reflecting expanding market share and client demand.
• With roughly 20% of shares sold short and bullish analyst upgrades following earnings, conditions appear favorable for a potential short squeeze in AMPX stock.
• Amprius faces execution risk as it shifts toward asset-light contract manufacturing with partners in South Korea and the U.S. to scale production and meet demand.

Amprius Technologies’ NYSE: AMPX Q2 results and guidance validated its growth trajectory, showing deepening penetration with a growing number of clients and strength in key battery markets, including drones and e-mobility. The net result is increased guidance underpinned by increased market share, with the total addressable market also expanding.

What comes next is execution: executing on the pilot-line expansion, leaning on contract manufacturing partners, ramping production, and delivering on the growing backlog. Given the stock’s deep price discount and high short interest, the next move will likely be a robust stock price upswing, potentially punctuated by news-driven sell-offs.

Amprius Technologies Short Market Sets Stage for Robust Rebound

Today's stock price discount is largely due to short sellers. Short sellers have had ample reason to sell into this market, given Amprius Technologies' recent pre-revenue status, losses, and uncertain capacity to execute strategy. However, the Q2 release indicates that revenue is ramping up faster than expected, driving an accelerating outlook for future growth. Losses persist but are rapidly shrinking and offset by the same outlook for future growth and a healthy balance sheet.

Short sellers have a growing impetus to cover positions and may amplify upside movements in upcoming months, and a short-squeeze is possible if a strong enough catalyst emerges. At 20% short, available shares will dry up quickly in the event of a strong buy trigger, setting the stage for a short squeeze if covering hasn’t already begun.

Institutions and Analysts Signal Support for AMPX Stock

Institutional and analyst activity highlight the potential for a squeeze. The initial analyst response following the earnings release was bullish, highlighting the pipeline strength, new contracts, and industry validation from key players such as Redwire NYSE: RDW and Stark Future.

Redwire is using SiCore battery cells in its Stalker Block 30 drones, intended for long-range surveillance, reconnaissance, and defense applications: Stark Future and Amprius are partnering on platforms for next-generation electric motorcycles and mobility, with the contract estimated at over $100 million in revenue by 2028.

Analyst trends are robustly bullish, including multiple price target increases, upgrades, and initiations since the last release. The group reflects modest and improving conviction in the Moderate Buy rating, with coverage up by 70% over the trailing 12 months, sentiment firming, and price targets moving to the high end of the range. Summer activity included a fresh price target above $30, indicating potential for approximately 200% upside relative to early August lows, and 90% upside at consensus.

Institutional support is less robust, with the group owning only 5% of the stock, but they have been accumulating over the trailing 12-month (TTM) period. The pace in early Q3 reflected aggressive activity ahead of the release, and the post-release price action suggests it continued afterward.

AMPX Market Signals Rebound Ahead

AMPX jumped by 8% the day of its Q2 release, confirming support at long-term lows, prior lows and a previous pivot point aligning with the 150-week exponential moving average. The move signals strong support at a convergence of support targets which are unlikely to be broken moving forward.

Critical highlights from the release included 125% year-over-year revenue growth, outperformance, and improved guidance, likely to be cautious when viewed in hindsight.

The most likely stock price scenario is that AMPX continues its evolving uptrend, volatile as it may be, potentially retesting the existing high before year’s end. Resistance targets near $15 and $20 are unlikely to impair price action in the long run; the more critical target is the existing highs near $22. Even so, momentum indicators suggest a new high can be set; the risk is that it won’t be sustained and AMPX will enter another deep correction at some point in the future.

Amprius' single biggest risk is also among its biggest opportunities: the shift to asset-light contract manufacturing. The company has a pilot line and is expanding capacity there, but shifted from building a manufacturing hub to utilizing a contract model. The benefit is seen in the margin and balance sheet, which reflect significant improvements and unlocked value; the risk is in 3rd-party dependence and potential bottlenecks.

Offsetting factors include expanding contract partners, such as in South Korea and the U.S., which has a double impact. South Korean and U.S. partners improve and solidify Amprius National Defense Authorization Act compliance and domestic capacity, opening the doors to new and larger U.S. contracts. Upcoming results will reflect the company’s ability to control its risks and execute strategy and will be catalysts for this market. Delays and missteps will not be tolerated well.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source